15 alpha Hydroxy Estriol,
15 alpha Hydroxyestriol,
15 alpha-Hydroxyestriol,
15-alpha-Hydroxy-Estriol,
Estetrol,
ESTETROL,
15183-37-6,
UNII-ENB39R14VF,
ENB39R14VF,
Estetrol [USAN],
(14beta,15alpha,16alpha,17alpha)-Estra-1,3,5(10)-Triene-3,15,16,17-Tetrol,
(8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol,
(8R,9S,13S,14S,15R,16R,17R)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,15,16,17-tetraol,
estell,
estetrolum,
oestetrol,
Donesta,
15|A-Hydroxyestriol,
15alpha-hydroxyestriol,
AC1L1CJT,
E4,
MLS006010253,
SCHEMBL145580,
Estetrol, >=98% (HPLC),
CHEMBL1230314,
CTK8F9498,
DTXSID50164888,
AJIPIJNNOJSSQC-NYLIRDPKSA-N,
CHEBI:142773,
BDBM158505,
ZINC5764481,
WHO 10439,
AKOS030254521,
DB12235,
SMR004701329,
US9034854, E4,
J-008852,
1,3,5(10)-estratrien-3,15alpha,16alpha,17beta-tetrol,
3,15|A,16|A,17|A-Tetrahydroxyestra-1,3,5(10)-triene,
estra-1(10),2,4-triene-3,15alpha,16alpha,17beta-tetrol,
Estra-1,3,5(10)-triene-3,15|A,16|A,17|A-tetrol,
estra-1,3,5(10)-triene-3,15alpha,16alpha,17beta-tetrol,
3,15alpha,16alpha,17beta-tetrahydroxyestra-1,3,5(10)-triene,
Estra-1,3,5(10)-triene-3,15 alpha,16alpha,17beta-tetrol,
(15|A,16|A,17|A)-Estra-1,3,5(10)-triene-3,15,16,17-tetrol,
(15alpha,16alpha,17beta)-estra-1(10),2,4-triene-3,15,16,17-tetrol,
Estra-1,3,5(10)-triene-3,15,16,17-tetrol, (15alpha,16alpha,17beta)-,
4OH,
D0L3TR,
Cid 6453561,
CID27125,
C18-H24-O4,
Estetrol (oral, contraception/hormone deficiency/osteoporosis/cardiovascular disease/autoimmune disease/breast cancer/prostate cancer),
Estetrol (oral, contraception/hormone deficiency/osteoporosis/cardiovascular disease/autoimmune disease/breast cancer/prostate cancer), Pantarhei,
Estrogen receptor modulator (oral, contraception/hormone deficiency/autoimmune disease/breast cancer/prostate cancer/osteoporosis/cardiovascular disease), Pantarhei,